Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic

Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19

Résumé en anglais

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in a global pandemic. It is hypothesized that the virus spreads from person to person via respiratory droplets or contact with contaminated surfaces and objects.1,2 Prior studies evaluating environmental contamination with SARS-CoV-2 have been conducted in health care settings treating patients known to have coronavirus disease 2019 (COVID-19)3; however, studies evaluating clinics that do not routinely treat patients with COVID-19 are lacking. Patients who have cancer and become infected with SARS-CoV-2 may have greater morbidity and mortality compared with the general public.4 Therefore, assessing the presence or absence of SARS-CoV-2 may provide important information for health care practitioners, patients, and their families, who must weigh the benefit of cancer treatment vs the risk of infection with SARS-CoV-2.